Emerson to Automate Arthritis Drug Plant
November 8, 2011
Hanwha Chemical, Seoul, has selected Emerson Process Management, Austin, Texas, to supply and commission its DeltaV digital automation system for a pharmaceutical production facility in Osong Bio-technology Technopolis, Chungcheongbuk-do, Korea. Known as the Eagle Project, the facility will manufacture Hanwha’s biosimilar rheumatoid arthritis drug HD203. The DeltaV system will play a key role in automating the facility’s biotechnology process and support the compliance requirements for FDA approval. Project completion is planned for 2012.
Biomedicine is a new business sector through which Hanhwa aims to become a global leader specializing in antibody production.
“The project is truly meaningful for both Hanhwa Chemical and Emerson,” says Yi Gil-seon, the Eagle Project’s plant manager at Hanwha Chemical. "The DeltaV system provides functionality that reduces wiring and decreases site construction costs by using electronic marshalling panels. This solution will help reduce construction time by as much as half, which will facilitate the rapid commercialization the product.”
The 2,900-I/O Eagle Project will consolidate its plant process using an integrated system of Emerson’s DeltaV S-Series, AMS Suite asset management software, and audit/change control functionality that supports validation requirements.
Emerson will provide a total of 34 electronic marshalling panels, 10 operator workstations installed in the clean room process areas, five manager workstations and five server stations. The server stations will be used for the process historical data collection, alarm management, complete batch control and diagnosis of the engineering and control systems.
According to Emerson, electronic marshalling will not only reduce site construction time and cost, but also provide a complete solution for future I/O expansion and plant management because it can be installed in the proximity of devices in the process area and provide the ultimate in flexibility, allowing users to choose I/O type on a channel-by-channel basis.
Emerson’s AMS Suite asset management software will be used during installation of measurement and control devices to help reduce costs and improve device startup efficiency. On an ongoing basis, AMS Suite will provide online access to instrument and valve predictive diagnostic information and automatic documentation of field-device maintenance.
The DeltaV digital automation system helps improve process manufacturing operations by harnessing today’s predictive technologies in an easy, intuitive, and interoperable way to connect people, processes and production, Emerson says. To learn more about DeltaV, go to www.deltav.com.